- Vedolizumab does not increase perioperative surgical complications in patients with inflammatory bowel disease, cohort study
-
Poylin VY, Serrato JC, Pastrana Del Valle J, Feuerstein JD
- KMID: 2525074
- Intest Res.
- 2022 Jan;20(1):72-77.
- doi: 10.5217/ir.2020.00117
Background/Aims: Biologics are increasingly used to manage ulcerative colitis (UC) and Crohn’s disease (CD). However, even with earlier usage of biologic therapy, a significant proportion of patients will require surgery.... -
- CITED
-
- Close
- SHARE
-
- Close
